Type: Paraprobiotics/Postbiotics
Application: Supplement & Nutrition

Comprehensive Immune Activation

IMMUSE is a novel paraprobiotic which is a patented strain of Lactococcus lactis that provides clinically researched immune support*. A strong immune system is crucial to maintaining good health. Today’s consumers face a constant onslaught on their immune systems from the stresses of modern life, work, diet and other lifestyle factors. With a unique mechanism of action that activates pDC (plasmacytoid dendritic cells), IMMUSE™ is a novel solution for your next immunity product.

Kyowa Hakko awardIMMUSE™ Earns Frost & Sullivan 2021 New Product Innovation Award

Add IMMUSE to your next product

Contact us for product information

Related News

Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™

September 21, 2021Santa Clara, CA

The solution offers superior ease of formulation, potential application versatility, and more comprehensive immune support compared to probiotics and other immune health ingredients. Read more »

Kirin Holdings to Double Lactococcus Lactis Strain Plasma Production

September 9, 2021Tokyo, Japan

Kirin Holdings Company, Limited (Kirin Holdings) announces that it will expand manufacturing equipment at the iMUSE Health Science Factory (located in Saitama Prefecture, just north of Tokyo) - a manufacturing center for lactic acid bacteria raw material - in order to meet the increasing demand for Kirin's proprietary Lactococcus lactis strain Plasma (L. lactis strain Plasma), the functional ingredient in the popular iMUSE brand of immune maintenance products. The new manufacturing equipment is scheduled to begin operating in 2023, and will double the annual production capacity of L. lactis strain Plasma to approximately 28 tons in 2023. Read more »